SIMILAR PATTERNS OF AMINO ACIDS FOR 1FKL_A_RAPA108_1
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1e1c | METHYLMALONYL-COAMUTASE ALPHA CHAIN (Propionibacteriumfreudenreichii) |
PF01642(MM_CoA_mutase)PF02310(B12-binding) | 5 | GLU A 255ILE A 240TYR A 266ILE A 200ILE A 221 | None | 1.08A | 1fklA-1e1cA:undetectable | 1fklA-1e1cA:9.72 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ee0 | 2-PYRONE SYNTHASE (Gerbera hybridcultivar) |
PF00195(Chal_sti_synt_N)PF02797(Chal_sti_synt_C) | 5 | ASP A 352VAL A 194ILE A 193ILE A 241ILE A 24 | None | 1.08A | 1fklA-1ee0A:undetectable | 1fklA-1ee0A:13.37 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 6 | ASP A 142PHE A 153TRP A 162TYR A 185ILE A 194PHE A 202 | None | 1.16A | 1fklA-1fd9A:16.0 | 1fklA-1fd9A:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fd9 | PROTEIN (MACROPHAGEINFECTIVITYPOTENTIATOR PROTEIN) (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 8 | TYR A 131ASP A 142VAL A 158ILE A 159TRP A 162TYR A 185ILE A 194PHE A 202 | None | 0.63A | 1fklA-1fd9A:16.0 | 1fklA-1fd9A:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 9 | TYR A 26ASP A 37ILE A 56TRP A 59TYR A 82HIS A 87ILE A 90ILE A 91PHE A 99 | None | 0.71A | 1fklA-1fkkA:22.2 | 1fklA-1fkkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 10 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82ILE A 90ILE A 91PHE A 99 | None | 0.45A | 1fklA-1fkkA:22.2 | 1fklA-1fkkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 9 | TYR A 26GLU A 54ILE A 56TRP A 59TYR A 82HIS A 87ILE A 90ILE A 91PHE A 99 | None | 0.77A | 1fklA-1fkkA:22.2 | 1fklA-1fkkA:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1fkk | FK506 BINDINGPROTEIN (Bos taurus) |
PF00254(FKBP_C) | 10 | TYR A 26PHE A 46GLU A 54VAL A 55ILE A 56TRP A 59TYR A 82ILE A 90ILE A 91PHE A 99 | None | 0.50A | 1fklA-1fkkA:22.2 | 1fklA-1fkkA:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1hxj | BETA-GLUCOSIDASE (Zea mays) |
PF00232(Glyco_hydro_1) | 6 | TYR A 163PHE A 151VAL A 140TRP A 96HIS A 137PHE A 166 | None | 1.38A | 1fklA-1hxjA:undetectable | 1fklA-1hxjA:14.08 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 7 | TYR A 92ASP A 103ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.64A | 1fklA-1jvwA:15.3 | 1fklA-1jvwA:42.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 8 | TYR A 92GLU A 118VAL A 119ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.44A | 1fklA-1jvwA:15.3 | 1fklA-1jvwA:42.06 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1jvw | MACROPHAGEINFECTIVITYPOTENTIATOR (Trypanosomacruzi) |
PF00254(FKBP_C) | 7 | TYR A 92PHE A 114ILE A 120TRP A 123TYR A 146ILE A 155PHE A 163 | None | 0.90A | 1fklA-1jvwA:15.3 | 1fklA-1jvwA:42.06 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 6 | TYR A 57PHE A 77ILE A 87TRP A 90ILE A 122PHE A 130 | None | 0.99A | 1fklA-1kt1A:15.5 | 1fklA-1kt1A:24.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 6 | TYR A 57PHE A 77ILE A 87TRP A 90TYR A 113PHE A 130 | None | 0.82A | 1fklA-1kt1A:15.5 | 1fklA-1kt1A:24.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 5 | TYR A 57PHE A 77VAL A 86TRP A 90ILE A 122 | None | 0.87A | 1fklA-1kt1A:15.5 | 1fklA-1kt1A:24.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1kt1 | FK506-BINDINGPROTEIN FKBP51 (Saimiriboliviensis) |
PF00254(FKBP_C)PF00515(TPR_1)PF13181(TPR_8) | 6 | TYR A 57PHE A 77VAL A 86TRP A 90TYR A 113PHE A 130 | None | 0.71A | 1fklA-1kt1A:15.5 | 1fklA-1kt1A:24.26 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n1a | FKBP52 (Homo sapiens) |
PF00254(FKBP_C) | 10 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.72A | 1fklA-1n1aA:18.2 | 1fklA-1n1aA:45.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1n1a | FKBP52 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 122 | None | 1.00A | 1fklA-1n1aA:18.2 | 1fklA-1n1aA:45.74 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1pbk | FKBP25 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 135ASP A 146VAL A 171ILE A 172TRP A 175TYR A 198ILE A 208PHE A 216 | RAP A 225 (-3.9A)RAP A 225 (-3.0A)RAP A 225 (-3.5A)RAP A 225 (-3.9A)RAP A 225 (-3.4A)RAP A 225 (-4.6A)RAP A 225 ( 4.9A)None | 0.31A | 1fklA-1pbkA:19.6 | 1fklA-1pbkA:44.17 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1q6h | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKPA (Escherichiacoli) |
PF00254(FKBP_C)PF01346(FKBP_N) | 8 | TYR A 146ASP A 157VAL A 173ILE A 174TRP A 177TYR A 200ILE A 208PHE A 216 | None | 0.56A | 1fklA-1q6hA:15.9 | 1fklA-1q6hA:32.16 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 8 | TYR A 40ASP A 51PHE A 60VAL A 69ILE A 70TRP A 73ILE A 105PHE A 113 | None | 0.62A | 1fklA-1r9hA:20.0 | 1fklA-1r9hA:45.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 6 | TYR A 40ASP A 51PHE A 60VAL A 69TRP A 73ILE A 105 | None | 1.26A | 1fklA-1r9hA:20.0 | 1fklA-1r9hA:45.45 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1r9h | FK506 BINDINGPROTEIN FAMILY (Caenorhabditiselegans) |
PF00254(FKBP_C) | 8 | TYR A 40PHE A 60VAL A 69ILE A 70TRP A 73TYR A 96ILE A 105PHE A 113 | None | 0.39A | 1fklA-1r9hA:20.0 | 1fklA-1r9hA:45.45 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 1ry2 | ACETYL-COENZYME ASYNTHETASE 1 (Saccharomycescerevisiae) |
PF00501(AMP-binding)PF13193(AMP-binding_C)PF16177(ACAS_N) | 5 | PHE A 349VAL A 466ILE A 465TYR A 454ILE A 458 | None | 1.11A | 1fklA-1ry2A:undetectable | 1fklA-1ry2A:9.81 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u79 | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE3 (Arabidopsisthaliana) |
PF00254(FKBP_C) | 9 | TYR A 37ASP A 48GLU A 65VAL A 66ILE A 67TRP A 70TYR A 99ILE A 113PHE A 121 | None | 0.53A | 1fklA-1u79A:17.6 | 1fklA-1u79A:36.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1u79 | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE3 (Arabidopsisthaliana) |
PF00254(FKBP_C) | 5 | TYR A 37ASP A 48GLU A 65VAL A 66ILE A 113 | None | 1.10A | 1fklA-1u79A:17.6 | 1fklA-1u79A:36.92 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yat | FK506 BINDINGPROTEIN (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 9 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 56TRP A 59TYR A 82ILE A 91PHE A 99 | FK5 A 108 ( 4.0A)FK5 A 108 ( 3.3A)FK5 A 108 ( 4.0A)FK5 A 108 ( 3.4A)FK5 A 108 ( 3.7A)FK5 A 108 ( 3.6A)FK5 A 108 ( 4.7A)NoneNone | 0.36A | 1fklA-1yatA:20.6 | 1fklA-1yatA:57.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 1yat | FK506 BINDINGPROTEIN (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 5 | TYR A 26ASP A 37PHE A 46VAL A 55ILE A 91 | FK5 A 108 ( 4.0A)FK5 A 108 ( 3.3A)FK5 A 108 ( 4.0A)FK5 A 108 ( 3.4A)None | 1.10A | 1fklA-1yatA:20.6 | 1fklA-1yatA:57.41 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lpv | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Aedes aegypti) |
PF00254(FKBP_C) | 6 | TYR A 27GLU A 55VAL A 56ILE A 57TRP A 60ILE A 92 | None | 1.02A | 1fklA-2lpvA:17.8 | 1fklA-2lpvA:72.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2lpv | FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Aedes aegypti) |
PF00254(FKBP_C) | 6 | TYR A 27PHE A 47GLU A 55ILE A 57TRP A 60ILE A 92 | None | 1.00A | 1fklA-2lpvA:17.8 | 1fklA-2lpvA:72.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | PEG A 201 (-4.4A)NonePEG A 201 ( 3.9A)PEG A 201 (-3.6A)PEG A 201 (-3.8A)PEG A 201 (-3.7A)NoneNoneNone | 0.88A | 1fklA-2pbcA:15.8 | 1fklA-2pbcA:46.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2pbc | FK506-BINDINGPROTEIN 2 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 121 | PEG A 201 (-4.4A)NonePEG A 201 ( 3.9A)PEG A 201 (-3.6A)None | 0.97A | 1fklA-2pbcA:15.8 | 1fklA-2pbcA:46.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | ASP A 66VAL A 82ILE A 83TRP A 86PHE A 126 | RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 ( 4.7A) | 0.86A | 1fklA-2vcdA:13.6 | 1fklA-2vcdA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 55ASP A 66VAL A 82ILE A 83TRP A 86 | RAP A 138 (-2.6A)RAP A 138 (-2.7A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A) | 0.84A | 1fklA-2vcdA:13.6 | 1fklA-2vcdA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vcd | OUTER MEMBRANEPROTEIN MIP (Legionellapneumophila) |
PF00254(FKBP_C)PF01346(FKBP_N) | 5 | TYR A 55VAL A 82ILE A 83TRP A 86TYR A 109 | RAP A 138 (-2.6A)RAP A 138 (-3.2A)RAP A 138 (-3.6A)RAP A 138 (-2.3A)RAP A 138 (-3.8A) | 0.72A | 1fklA-2vcdA:13.6 | 1fklA-2vcdA:35.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vn1 | 70 KDAPEPTIDYLPROLYLISOMERASE (Plasmodiumfalciparum) |
PF00254(FKBP_C) | 10 | TYR A 44ASP A 56PHE A 65GLU A 73VAL A 74ILE A 75TRP A 78TYR A 101ILE A 110PHE A 118 | FK5 A 501 (-4.1A)FK5 A 501 (-3.4A)FK5 A 501 (-4.1A)NoneFK5 A 501 (-3.5A)FK5 A 501 (-4.3A)FK5 A 501 (-3.3A)FK5 A 501 (-4.7A)NoneFK5 A 501 (-4.8A) | 0.44A | 1fklA-2vn1A:19.8 | 1fklA-2vn1A:41.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2vn1 | 70 KDAPEPTIDYLPROLYLISOMERASE (Plasmodiumfalciparum) |
PF00254(FKBP_C) | 6 | TYR A 44ASP A 56PHE A 65GLU A 73VAL A 74ILE A 110 | FK5 A 501 (-4.1A)FK5 A 501 (-3.4A)FK5 A 501 (-4.1A)NoneFK5 A 501 (-3.5A)None | 1.23A | 1fklA-2vn1A:19.8 | 1fklA-2vn1A:41.09 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 8 | TYR A 33ASP A 44PHE A 53VAL A 62TRP A 66TYR A 89ILE A 98PHE A 106 | None | 0.71A | 1fklA-2y78A:18.0 | 1fklA-2y78A:52.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 2y78 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 8 | TYR A 33PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | None | 0.46A | 1fklA-2y78A:18.0 | 1fklA-2y78A:52.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2zy2 | L-ASPARTATE4-CARBOXYLYASE (Pseudomonas sp.ATCC 19121) |
PF00155(Aminotran_1_2) | 5 | ASP A 286PHE A 204ILE A 210ILE A 181PHE A 250 | PLP A 900 (-3.2A)PLP A 900 (-4.2A)NoneNoneNone | 1.07A | 1fklA-2zy2A:undetectable | 1fklA-2zy2A:11.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | None | 0.78A | 1fklA-3o5dA:18.9 | 1fklA-3o5dA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5d | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.66A | 1fklA-3o5dA:18.9 | 1fklA-3o5dA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 87TYR A 113ILE A 122PHE A 130 | None | 0.80A | 1fklA-3o5eA:18.8 | 1fklA-3o5eA:40.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 57ASP A 68PHE A 77VAL A 86ILE A 122 | None | 1.08A | 1fklA-3o5eA:18.8 | 1fklA-3o5eA:40.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3o5e | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 7 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90ILE A 122PHE A 130 | None | 0.82A | 1fklA-3o5eA:18.8 | 1fklA-3o5eA:40.28 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 6 | TYR A 43ASP A 55PHE A 64GLU A 72VAL A 73ILE A 109 | None | 1.02A | 1fklA-3pa7A:19.3 | 1fklA-3pa7A:40.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 8 | TYR A 43ASP A 55PHE A 64GLU A 72VAL A 73TRP A 77ILE A 109PHE A 117 | None | 0.68A | 1fklA-3pa7A:19.3 | 1fklA-3pa7A:40.91 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 3pa7 | 70 KDAPEPTIDYLPROLYLISOMERASE, PUTATIVE (Plasmodiumvivax) |
PF00254(FKBP_C) | 9 | TYR A 43PHE A 64GLU A 72VAL A 73ILE A 74TRP A 77TYR A 100ILE A 109PHE A 117 | None | 0.51A | 1fklA-3pa7A:19.3 | 1fklA-3pa7A:40.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sqw | ATP-DEPENDENT RNAHELICASE MSS116,MITOCHONDRIAL (Saccharomycescerevisiae) |
PF00270(DEAD)PF00271(Helicase_C) | 5 | ASP A 343VAL A 498ILE A 497TYR A 460ILE A 464 | None | 1.02A | 1fklA-3sqwA:undetectable | 1fklA-3sqwA:12.99 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3wq1 | ENDOGLUCANASE A (Pyrococcusfuriosus) |
PF01670(Glyco_hydro_12) | 5 | ASP A 111GLU A 302VAL A 107ILE A 113ILE A 86 | None | 1.05A | 1fklA-3wq1A:undetectable | 1fklA-3wq1A:17.20 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 5 | GLU A 340VAL A 341TRP A 345ILE A 376PHE A 384 | None | 1.11A | 1fklA-4bf8A:16.6 | 1fklA-4bf8A:39.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 313ASP A 324PHE A 332VAL A 341ILE A 342TRP A 345PHE A 384 | None | 0.83A | 1fklA-4bf8A:16.6 | 1fklA-4bf8A:39.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 8 | TYR A 313ASP A 324VAL A 341ILE A 342TRP A 345TYR A 368ILE A 376PHE A 384 | None | 0.79A | 1fklA-4bf8A:16.6 | 1fklA-4bf8A:39.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 8 | TYR A 313GLU A 340VAL A 341ILE A 342TRP A 345TYR A 368ILE A 376PHE A 384 | None | 1.09A | 1fklA-4bf8A:16.6 | 1fklA-4bf8A:39.50 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4bf8 | FPR4 (Saccharomycescerevisiae) |
PF00254(FKBP_C) | 7 | TYR A 313PHE A 332GLU A 340VAL A 341ILE A 342TRP A 345PHE A 384 | None | 1.13A | 1fklA-4bf8A:16.6 | 1fklA-4bf8A:39.50 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4db1 | MYOSIN-7 (Homo sapiens) |
PF00063(Myosin_head)PF02736(Myosin_N) | 5 | ASP A 461GLU A 328ILE A 248ILE A 263PHE A 244 | MN A 802 ( 4.1A)NoneNoneNoneNone | 0.95A | 1fklA-4db1A:undetectable | 1fklA-4db1A:9.03 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4db4 | ATP-DEPENDENT RNAHELICASE MSS116,MITOCHONDRIAL (Saccharomycescerevisiae) |
PF00271(Helicase_C) | 5 | ASP A 343VAL A 498ILE A 497TYR A 460ILE A 464 | None | 1.06A | 1fklA-4db4A:undetectable | 1fklA-4db4A:18.36 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dip | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 52GLU A 83TYR A 111ILE A 119PHE A 127 | None | 0.81A | 1fklA-4dipA:17.3 | 1fklA-4dipA:35.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dip | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 52TRP A 88TYR A 111ILE A 119PHE A 127 | None | 0.59A | 1fklA-4dipA:17.3 | 1fklA-4dipA:35.43 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4dz3 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei) |
PF00254(FKBP_C) | 9 | TYR A 33ASP A 44PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | FK5 A 201 ( 3.9A)FK5 A 201 (-3.5A)FK5 A 201 (-4.1A)FK5 A 201 ( 3.6A)FK5 A 201 (-3.8A)FK5 A 201 (-3.4A)FK5 A 201 (-4.7A)NoneFK5 A 201 (-4.8A) | 0.34A | 1fklA-4dz3A:18.9 | 1fklA-4dz3A:54.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4fx0 | PROBABLETRANSCRIPTIONALREPRESSOR PROTEIN (Mycobacteriumtuberculosis) |
PF12802(MarR_2) | 5 | GLU A 69VAL A 68ILE A 66ILE A 99ILE A 46 | None | 1.06A | 1fklA-4fx0A:undetectable | 1fklA-4fx0A:20.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4gnk | 1-PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATEPHOSPHODIESTERASEBETA-3 (Homo sapiens) |
PF00168(C2)PF00387(PI-PLC-Y)PF00388(PI-PLC-X)PF09279(EF-hand_like) | 5 | ASP B 851GLU B 717VAL B 718ILE B 719TYR B 847 | None | 0.90A | 1fklA-4gnkB:undetectable | 1fklA-4gnkB:6.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4h65 | PYRIMIDINE PRECURSORBIOSYNTHESIS ENZYMETHI5 (Saccharomycescerevisiae) |
PF09084(NMT1) | 5 | PHE A 209GLU A 215VAL A 217ILE A 39ILE A 21 | None | 1.04A | 1fklA-4h65A:undetectable | 1fklA-4h65A:16.15 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 26ASP A 37PHE A 46GLU A 54TYR A 82HIS A 87ILE A 91PHE A 99 | None | 0.83A | 1fklA-4iqcA:21.6 | 1fklA-4iqcA:85.05 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4iqc | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1B (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 26PHE A 46GLU A 54VAL A 55ILE A 56TYR A 82HIS A 87ILE A 91PHE A 99 | None | 0.75A | 1fklA-4iqcA:21.6 | 1fklA-4iqcA:85.05 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4ix1 | HYPOTHETICAL PROTEIN (Rhodococcusopacus) |
no annotation | 5 | TYR A 146GLU A 121VAL A 120ILE A 155ILE A 204 | None | 1.08A | 1fklA-4ix1A:undetectable | 1fklA-4ix1A:20.63 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90PHE A 130 | NoneNoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)DMS A 304 (-4.3A) | 0.56A | 1fklA-4lawA:19.6 | 1fklA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 6 | TYR A 57ASP A 68PHE A 77GLU A 85VAL A 86ILE A 122 | NoneNoneNoneNoneDMS A 304 (-3.5A)None | 0.86A | 1fklA-4lawA:19.6 | 1fklA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4law | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP4 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 57PHE A 77GLU A 85VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | NoneNoneNoneDMS A 304 (-3.5A)DMS A 304 (-3.8A)DMS A 304 ( 4.0A)NoneNoneDMS A 304 (-4.3A) | 0.57A | 1fklA-4lawA:19.6 | 1fklA-4lawA:24.39 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4lde | LYSOZYME, BETA-2ADRENERGIC RECEPTOR (Escherichiavirus T4;Homo sapiens) |
PF00001(7tm_1)PF00959(Phage_lysozyme) | 5 | TYR A1199GLU A1122VAL A1206ILE A1205ILE A1294 | None | 1.09A | 1fklA-4ldeA:undetectable | 1fklA-4ldeA:12.89 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4msp | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C)PF13499(EF-hand_7) | 5 | TYR A 33GLU A 64TYR A 92ILE A 100PHE A 108 | None | 0.75A | 1fklA-4mspA:18.0 | 1fklA-4mspA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4msp | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP14 (Homo sapiens) |
PF00254(FKBP_C)PF13499(EF-hand_7) | 5 | TYR A 33TRP A 69TYR A 92ILE A 100PHE A 108 | None | 0.52A | 1fklA-4mspA:18.0 | 1fklA-4mspA:33.33 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4nnr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP2 (Homo sapiens) |
PF00254(FKBP_C) | 9 | TYR A 56ASP A 67PHE A 76VAL A 85ILE A 86TRP A 89TYR A 112ILE A 121PHE A 129 | FK5 A 201 (-4.1A)FK5 A 201 (-3.4A)FK5 A 201 (-4.0A)FK5 A 201 (-3.4A)FK5 A 201 (-3.8A)FK5 A 201 (-3.5A)FK5 A 201 (-4.5A)NoneFK5 A 201 (-4.9A) | 0.36A | 1fklA-4nnrA:16.5 | 1fklA-4nnrA:39.42 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4oa7 | TANKYRASE-1 (Homo sapiens) |
PF00644(PARP) | 5 | TYR A1203GLU A1291ILE A1212ILE A1189ILE A1192 | 2XS A1402 (-3.1A)None2XS A1402 ( 4.3A)None2XS A1402 ( 4.7A) | 0.94A | 1fklA-4oa7A:undetectable | 1fklA-4oa7A:20.29 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4odm | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD (Thermusthermophilus) |
PF00254(FKBP_C) | 5 | TYR A 13ASP A 23ILE A 37TYR A 63PHE A 128 | None | 0.57A | 1fklA-4odmA:11.9 | 1fklA-4odmA:23.35 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4odr | PEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A CHIMERA (Homo sapiens;Thermusthermophilus) |
PF00254(FKBP_C) | 8 | TYR A 13ASP A 23ILE A 37TYR A 63HIS A 68ILE A 71ILE A 72PHE A 80 | FK5 A 201 ( 3.6A)FK5 A 201 (-3.6A)FK5 A 201 (-3.9A)FK5 A 201 (-4.4A)NoneFK5 A 201 ( 4.1A)NoneFK5 A 201 ( 4.8A) | 0.67A | 1fklA-4odrA:13.6 | 1fklA-4odrA:32.79 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4opw | UNCHARACTERIZEDPROTEIN (Parabacteroidesmerdae) |
PF10988(DUF2807) | 5 | ASP A 68VAL A 49ILE A 50ILE A 65PHE A 88 | NoneNoneNoneNoneEDO A 301 (-4.3A) | 1.00A | 1fklA-4opwA:undetectable | 1fklA-4opwA:20.75 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 5 | TYR A 57ASP A 68PHE A 77VAL A 86PHE A 130 | None | 0.69A | 1fklA-4r0xA:19.1 | 1fklA-4r0xA:45.90 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4r0x | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP5 (Homo sapiens) |
PF00254(FKBP_C) | 8 | TYR A 57PHE A 77VAL A 86ILE A 87TRP A 90TYR A 113ILE A 122PHE A 130 | None | 0.75A | 1fklA-4r0xA:19.1 | 1fklA-4r0xA:45.90 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4zmh | UNCHARACTERIZEDPROTEIN (Saccharophagusdegradans) |
PF15979(Glyco_hydro_115) | 5 | ASP A 944PHE A 845ILE A 840TYR A 459ILE A 883 | None | 1.07A | 1fklA-4zmhA:undetectable | 1fklA-4zmhA:7.73 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5b8i | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Coccidioidesimmitis) |
PF00254(FKBP_C) | 9 | TYR C 36ASP C 56PHE C 64VAL C 73ILE C 74TRP C 77TYR C 100ILE C 109PHE C 117 | FK5 C 201 (-4.1A)FK5 C 201 ( 3.8A)FK5 C 201 (-3.8A)FK5 C 201 (-3.5A)FK5 C 201 (-3.8A)FK5 C 201 (-3.4A)FK5 C 201 (-4.5A)NoneFK5 C 201 (-4.7A) | 0.32A | 1fklA-5b8iC:20.1 | 1fklA-5b8iC:41.98 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7p | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPEPEPTIDYL-PROLYLCIS-TRANS ISOMERASESLYD,PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 10 | TYR A 26ASP A 37PHE A 46GLU A 54VAL A 55ILE A 56TRP A 59TYR A 82HIS A 137PHE A 146 | None | 0.89A | 1fklA-5i7pA:20.3 | 1fklA-5i7pA:61.69 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i7q | PEPTIDYL-PROLYLCIS-TRANS ISOMERASEFKBP1A,FKBP-TYPE 16KDA PEPTIDYL-PROLYLCIS-TRANSISOMERASE,PEPTIDYL-PROLYL CIS-TRANSISOMERASE FKBP1A (Escherichiacoli;Homo sapiens) |
PF00254(FKBP_C) | 10 | TYR A 26ASP A 37PHE A 46GLU A 54VAL A 55ILE A 56TRP A 59TYR A 82HIS A 138PHE A 147 | None | 0.97A | 1fklA-5i7qA:20.6 | 1fklA-5i7qA:64.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 9 | TYR A 30ASP A 41PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 105ILE A 102 | None | 1.42A | 1fklA-5i98A:19.2 | 1fklA-5i98A:45.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 10 | TYR A 30ASP A 41PHE A 50VAL A 59ILE A 60TRP A 63TYR A 97ILE A 105ILE A 106PHE A 114 | None | 0.52A | 1fklA-5i98A:19.2 | 1fklA-5i98A:45.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5i98 | FK506-BINDINGPROTEIN 1 (Candidaalbicans) |
PF00254(FKBP_C) | 8 | TYR A 30ASP A 41PHE A 50VAL A 59TRP A 63ILE A 102ILE A 106PHE A 114 | None | 1.15A | 1fklA-5i98A:19.2 | 1fklA-5i98A:45.83 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 9 | TYR A 27ASP A 38PHE A 47VAL A 56ILE A 57TRP A 60TYR A 83ILE A 92PHE A 100 | None | 0.65A | 1fklA-5j6eA:20.8 | 1fklA-5j6eA:58.88 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5j6e | FK506-BINDINGPROTEIN 1A (Aspergillusfumigatus) |
PF00254(FKBP_C) | 5 | TYR A 27ASP A 38PHE A 47VAL A 56ILE A 92 | None | 1.05A | 1fklA-5j6eA:20.8 | 1fklA-5j6eA:58.88 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5jcv | LMO2181 PROTEIN (Listeriamonocytogenes) |
PF04203(Sortase) | 5 | ASP A 125VAL A 75ILE A 89TYR A 161ILE A 221 | None | 1.02A | 1fklA-5jcvA:undetectable | 1fklA-5jcvA:15.87 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5msz | THERMOBIA DOMESTICADOMESTICA AA15 (Thermobiadomestica) |
no annotation | 5 | ASP A 84VAL A 72ILE A 190TYR A 75ILE A 81 | None | 1.08A | 1fklA-5mszA:undetectable | 1fklA-5mszA:20.22 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5nv6 | TRANSFORMING GROWTHFACTOR-BETA-INDUCEDPROTEIN IG-H3 (Homo sapiens) |
PF02469(Fasciclin) | 5 | PHE A 515GLU A 615VAL A 627ILE A 628ILE A 573 | None | 1.11A | 1fklA-5nv6A:undetectable | 1fklA-5nv6A:10.68 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5oyj | VASCULAR ENDOTHELIALGROWTH FACTORRECEPTOR 2 (Homo sapiens) |
no annotation | 5 | GLU C 540VAL C 542ILE C 543ILE C 497ILE C 519 | None | 0.95A | 1fklA-5oyjC:undetectable | 1fklA-5oyjC:20.91 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5v8t | UBIQUITIN-LIKEPROTEINSMT3,PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Burkholderiapseudomallei;Saccharomycescerevisiae) |
no annotation | 9 | TYR A 33ASP A 44PHE A 53VAL A 62ILE A 63TRP A 66TYR A 89ILE A 98PHE A 106 | 8ZV A 201 (-3.8A)8ZV A 201 (-3.9A)8ZV A 201 (-3.9A)8ZV A 201 (-3.6A)8ZV A 201 (-4.0A)8ZV A 201 (-3.3A)8ZV A 201 (-4.6A)8ZV A 201 ( 4.8A)8ZV A 201 (-4.6A) | 0.37A | 1fklA-5v8tA:18.9 | 1fklA-5v8tA:24.30 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 8 | TYR A 147ASP A 158VAL A 171ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.7A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 0.70A | 1fklA-5xb0A:15.5 | 1fklA-5xb0A:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 7 | TYR A 147PHE A 166ILE A 172TRP A 175TYR A 198ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 ( 4.6A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNoneNone | 1.01A | 1fklA-5xb0A:15.5 | 1fklA-5xb0A:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5xb0 | PEPTIDYL-PROLYLCIS-TRANS ISOMERASE (Pseudomonassyringae groupgenomosp. 3) |
PF00254(FKBP_C) | 5 | TYR A 147VAL A 171TRP A 175ILE A 207PHE A 215 | TLA A 301 ( 4.4A)TLA A 301 (-3.4A)TLA A 301 (-3.4A)NoneNone | 1.06A | 1fklA-5xb0A:15.5 | 1fklA-5xb0A:31.39 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 10 | TYR A 38ASP A 49PHE A 58GLU A 66VAL A 67ILE A 68TRP A 71TYR A 94ILE A 103PHE A 111 | None | 0.74A | 1fklA-6b4pA:19.5 | 1fklA-6b4pA:42.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 6 | TYR A 38ASP A 49PHE A 58GLU A 66VAL A 67ILE A 103 | None | 1.04A | 1fklA-6b4pA:19.5 | 1fklA-6b4pA:42.52 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 6b4p | PEPTIDYLPROLYLISOMERASE (Naegleriafowleri) |
no annotation | 6 | TYR A 38PHE A 58TRP A 71ILE A 99ILE A 103PHE A 111 | None | 1.41A | 1fklA-6b4pA:19.5 | 1fklA-6b4pA:42.52 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6fsa | - (-) |
no annotation | 5 | ASP A 461GLU A 328ILE A 248ILE A 263PHE A 244 | None | 1.10A | 1fklA-6fsaA:undetectable | 1fklA-6fsaA:undetectable |